Industry Research Reports

Home > Reports > Chemical & Material > Global Platinum-based Anticancer APIs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Platinum-based Anticancer APIs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-20

Pages: 107 Pages

Report ld: 4063347

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Platinum-based Anticancer APIs market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

With the continuous deepening of research, platinum anti-cancer APIs such as cisplatin, carboplatin, nedaplatin, cycloplatin, oxaliplatin, and loplatin have been developed around the world. At present, platinum-based anticancer APIs have developed into the third generation. The mainstream platinum-based anticancer APIs are cisplatin, carboplatin and oxaliplatin.

The global Platinum-based Anticancer APIs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Platinum-based Anticancer APIs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others

Segment by Application

Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of Platinum-based Anticancer APIs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Platinum-based Anticancer APIs manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Platinum-based Anticancer APIs revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Platinum-based Anticancer APIs Product Scope

1.2 Platinum-based Anticancer APIs by Type

1.2.1 Global Platinum-based Anticancer APIs Sales by Type (2020 & 2024 & 2031)

1.2.2 Cisplatin

1.2.3 Carboplatin

1.2.4 Oxaliplatin

1.2.5 Nedaplatin

1.2.6 Others

1.3 Platinum-based Anticancer APIs by Application

1.3.1 Global Platinum-based Anticancer APIs Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Testicular Cancer

1.3.3 Osteosarcoma

1.3.4 Breast Cancer

1.3.5 Esophageal Cancer

1.3.6 NSCLC

1.3.7 Other

1.4 Global Platinum-based Anticancer APIs Market Estimates and Forecasts (2020-2031)

1.4.1 Global Platinum-based Anticancer APIs Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Platinum-based Anticancer APIs Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Platinum-based Anticancer APIs Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Platinum-based Anticancer APIs Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Platinum-based Anticancer APIs Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Platinum-based Anticancer APIs Sales Market Share by Region (2020-2025)

2.2.2 Global Platinum-based Anticancer APIs Revenue Market Share by Region (2020-2025)

2.3 Global Platinum-based Anticancer APIs Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Platinum-based Anticancer APIs Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Platinum-based Anticancer APIs Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Platinum-based Anticancer APIs Market Size and Prospective (2020-2031)

2.4.2 Europe Platinum-based Anticancer APIs Market Size and Prospective (2020-2031)

2.4.3 China Platinum-based Anticancer APIs Market Size and Prospective (2020-2031)

2.4.4 India Platinum-based Anticancer APIs Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Platinum-based Anticancer APIs Historic Market Review by Type (2020-2025)

3.1.1 Global Platinum-based Anticancer APIs Sales by Type (2020-2025)

3.1.2 Global Platinum-based Anticancer APIs Revenue by Type (2020-2025)

3.1.3 Global Platinum-based Anticancer APIs Price by Type (2020-2025)

3.2 Global Platinum-based Anticancer APIs Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Platinum-based Anticancer APIs Sales Forecast by Type (2026-2031)

3.2.2 Global Platinum-based Anticancer APIs Revenue Forecast by Type (2026-2031)

3.2.3 Global Platinum-based Anticancer APIs Price Forecast by Type (2026-2031)

3.3 Different Types Platinum-based Anticancer APIs Representative Players

4 Global Market Size by Application

4.1 Global Platinum-based Anticancer APIs Historic Market Review by Application (2020-2025)

4.1.1 Global Platinum-based Anticancer APIs Sales by Application (2020-2025)

4.1.2 Global Platinum-based Anticancer APIs Revenue by Application (2020-2025)

4.1.3 Global Platinum-based Anticancer APIs Price by Application (2020-2025)

4.2 Global Platinum-based Anticancer APIs Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Platinum-based Anticancer APIs Sales Forecast by Application (2026-2031)

4.2.2 Global Platinum-based Anticancer APIs Revenue Forecast by Application (2026-2031)

4.2.3 Global Platinum-based Anticancer APIs Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Platinum-based Anticancer APIs Application

5 Competition Landscape by Players

5.1 Global Platinum-based Anticancer APIs Sales by Players (2020-2025)

5.2 Global Top Platinum-based Anticancer APIs Players by Revenue (2020-2025)

5.3 Global Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer APIs as of 2024)

5.4 Global Platinum-based Anticancer APIs Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Platinum-based Anticancer APIs, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Platinum-based Anticancer APIs, Product Type & Application

5.7 Global Key Manufacturers of Platinum-based Anticancer APIs, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Platinum-based Anticancer APIs Sales by Company

6.1.1.1 North America Platinum-based Anticancer APIs Sales by Company (2020-2025)

6.1.1.2 North America Platinum-based Anticancer APIs Revenue by Company (2020-2025)

6.1.2 North America Platinum-based Anticancer APIs Sales Breakdown by Type (2020-2025)

6.1.3 North America Platinum-based Anticancer APIs Sales Breakdown by Application (2020-2025)

6.1.4 North America Platinum-based Anticancer APIs Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Platinum-based Anticancer APIs Sales by Company

6.2.1.1 Europe Platinum-based Anticancer APIs Sales by Company (2020-2025)

6.2.1.2 Europe Platinum-based Anticancer APIs Revenue by Company (2020-2025)

6.2.2 Europe Platinum-based Anticancer APIs Sales Breakdown by Type (2020-2025)

6.2.3 Europe Platinum-based Anticancer APIs Sales Breakdown by Application (2020-2025)

6.2.4 Europe Platinum-based Anticancer APIs Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Platinum-based Anticancer APIs Sales by Company

6.3.1.1 China Platinum-based Anticancer APIs Sales by Company (2020-2025)

6.3.1.2 China Platinum-based Anticancer APIs Revenue by Company (2020-2025)

6.3.2 China Platinum-based Anticancer APIs Sales Breakdown by Type (2020-2025)

6.3.3 China Platinum-based Anticancer APIs Sales Breakdown by Application (2020-2025)

6.3.4 China Platinum-based Anticancer APIs Major Customer

6.3.5 China Market Trend and Opportunities

6.4 India Market: Players, Segments, Downstream and Major Customers

6.4.1 India Platinum-based Anticancer APIs Sales by Company

6.4.1.1 India Platinum-based Anticancer APIs Sales by Company (2020-2025)

6.4.1.2 India Platinum-based Anticancer APIs Revenue by Company (2020-2025)

6.4.2 India Platinum-based Anticancer APIs Sales Breakdown by Type (2020-2025)

6.4.3 India Platinum-based Anticancer APIs Sales Breakdown by Application (2020-2025)

6.4.4 India Platinum-based Anticancer APIs Major Customer

6.4.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Jiangsu Hengrui Medicine

7.1.1 Jiangsu Hengrui Medicine Company Information

7.1.2 Jiangsu Hengrui Medicine Business Overview

7.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Products Offered

7.1.5 Jiangsu Hengrui Medicine Recent Development

7.2 Nanjing Pharmaceutical Factory

7.2.1 Nanjing Pharmaceutical Factory Company Information

7.2.2 Nanjing Pharmaceutical Factory Business Overview

7.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Products Offered

7.2.5 Nanjing Pharmaceutical Factory Recent Development

7.3 Qilu Pharmaceutical

7.3.1 Qilu Pharmaceutical Company Information

7.3.2 Qilu Pharmaceutical Business Overview

7.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Qilu Pharmaceutical Platinum-based Anticancer APIs Products Offered

7.3.5 Qilu Pharmaceutical Recent Development

7.4 Neptunus

7.4.1 Neptunus Company Information

7.4.2 Neptunus Business Overview

7.4.3 Neptunus Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Neptunus Platinum-based Anticancer APIs Products Offered

7.4.5 Neptunus Recent Development

7.5 Hisun

7.5.1 Hisun Company Information

7.5.2 Hisun Business Overview

7.5.3 Hisun Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Hisun Platinum-based Anticancer APIs Products Offered

7.5.5 Hisun Recent Development

7.6 Jiangsu HaiCi biological pharmaceutical

7.6.1 Jiangsu HaiCi biological pharmaceutical Company Information

7.6.2 Jiangsu HaiCi biological pharmaceutical Business Overview

7.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Products Offered

7.6.5 Jiangsu HaiCi biological pharmaceutical Recent Development

7.7 Kunming Guiyan Pharmaceutical

7.7.1 Kunming Guiyan Pharmaceutical Company Information

7.7.2 Kunming Guiyan Pharmaceutical Business Overview

7.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Products Offered

7.7.5 Kunming Guiyan Pharmaceutical Recent Development

7.8 Lingnan Pharmacy

7.8.1 Lingnan Pharmacy Company Information

7.8.2 Lingnan Pharmacy Business Overview

7.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Lingnan Pharmacy Platinum-based Anticancer APIs Products Offered

7.8.5 Lingnan Pharmacy Recent Development

7.9 Jinzhou Jiutai Pharmaceutical

7.9.1 Jinzhou Jiutai Pharmaceutical Company Information

7.9.2 Jinzhou Jiutai Pharmaceutical Business Overview

7.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Products Offered

7.9.5 Jinzhou Jiutai Pharmaceutical Recent Development

7.10 Nanjing Hairun Pharmaceutical

7.10.1 Nanjing Hairun Pharmaceutical Company Information

7.10.2 Nanjing Hairun Pharmaceutical Business Overview

7.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Products Offered

7.10.5 Nanjing Hairun Pharmaceutical Recent Development

7.11 Simcere

7.11.1 Simcere Company Information

7.11.2 Simcere Business Overview

7.11.3 Simcere Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Simcere Platinum-based Anticancer APIs Products Offered

7.11.5 Simcere Recent Development

7.12 Teva

7.12.1 Teva Company Information

7.12.2 Teva Business Overview

7.12.3 Teva Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Teva Platinum-based Anticancer APIs Products Offered

7.12.5 Teva Recent Development

7.13 Cipla

7.13.1 Cipla Company Information

7.13.2 Cipla Business Overview

7.13.3 Cipla Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Cipla Platinum-based Anticancer APIs Products Offered

7.13.5 Cipla Recent Development

7.14 Heraeus

7.14.1 Heraeus Company Information

7.14.2 Heraeus Business Overview

7.14.3 Heraeus Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.14.4 Heraeus Platinum-based Anticancer APIs Products Offered

7.14.5 Heraeus Recent Development

7.15 Hospira(Pfizer)

7.15.1 Hospira(Pfizer) Company Information

7.15.2 Hospira(Pfizer) Business Overview

7.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.15.4 Hospira(Pfizer) Platinum-based Anticancer APIs Products Offered

7.15.5 Hospira(Pfizer) Recent Development

7.16 Taj Pharmaceuticals

7.16.1 Taj Pharmaceuticals Company Information

7.16.2 Taj Pharmaceuticals Business Overview

7.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.16.4 Taj Pharmaceuticals Platinum-based Anticancer APIs Products Offered

7.16.5 Taj Pharmaceuticals Recent Development

7.17 Umicore Precious Metals Chemistry

7.17.1 Umicore Precious Metals Chemistry Company Information

7.17.2 Umicore Precious Metals Chemistry Business Overview

7.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2020-2025)

7.17.4 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Products Offered

7.17.5 Umicore Precious Metals Chemistry Recent Development

8 Platinum-based Anticancer APIs Manufacturing Cost Analysis

8.1 Platinum-based Anticancer APIs Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Platinum-based Anticancer APIs

8.4 Platinum-based Anticancer APIs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Platinum-based Anticancer APIs Distributors List

9.3 Platinum-based Anticancer APIs Customers

10 Platinum-based Anticancer APIs Market Dynamics

10.1 Platinum-based Anticancer APIs Industry Trends

10.2 Platinum-based Anticancer APIs Market Drivers

10.3 Platinum-based Anticancer APIs Market Challenges

10.4 Platinum-based Anticancer APIs Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Platinum-based Anticancer APIs Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Platinum-based Anticancer APIs Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Platinum-based Anticancer APIs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Platinum-based Anticancer APIs Sales (MT) by Region (2020-2025)

Table 5. Global Platinum-based Anticancer APIs Sales Market Share by Region (2020-2025)

Table 6. Global Platinum-based Anticancer APIs Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Platinum-based Anticancer APIs Revenue Share by Region (2020-2025)

Table 8. Global Platinum-based Anticancer APIs Sales (MT) Forecast by Region (2026-2031)

Table 9. Global Platinum-based Anticancer APIs Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Platinum-based Anticancer APIs Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Platinum-based Anticancer APIs Revenue Share Forecast by Region (2026-2031)

Table 12. Global Platinum-based Anticancer APIs Sales by Type (MT) & (2020-2025)

Table 13. Global Platinum-based Anticancer APIs Sales Share by Type (2020-2025)

Table 14. Global Platinum-based Anticancer APIs Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Platinum-based Anticancer APIs Price by Type (US$/MT) & (2020-2025)

Table 16. Global Platinum-based Anticancer APIs Sales by Type (MT) & (2026-2031)

Table 17. Global Platinum-based Anticancer APIs Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Platinum-based Anticancer APIs Price by Type (US$/MT) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Platinum-based Anticancer APIs Sales by Application (MT) & (2020-2025)

Table 21. Global Platinum-based Anticancer APIs Sales Share by Application (2020-2025)

Table 22. Global Platinum-based Anticancer APIs Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Platinum-based Anticancer APIs Price by Application (US$/MT) & (2020-2025)

Table 24. Global Platinum-based Anticancer APIs Sales by Application (MT) & (2026-2031)

Table 25. Global Platinum-based Anticancer APIs Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Platinum-based Anticancer APIs Price by Application (US$/MT) & (2026-2031)

Table 27. New Sources of Growth in Platinum-based Anticancer APIs Application

Table 28. Global Platinum-based Anticancer APIs Sales by Company (MT) & (2020-2025)

Table 29. Global Platinum-based Anticancer APIs Sales Share by Company (2020-2025)

Table 30. Global Platinum-based Anticancer APIs Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Platinum-based Anticancer APIs Revenue Share by Company (2020-2025)

Table 32. Global Platinum-based Anticancer APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer APIs as of 2024)

Table 33. Global Market Platinum-based Anticancer APIs Average Price by Company (US$/MT) & (2020-2025)

Table 34. Global Key Manufacturers of Platinum-based Anticancer APIs, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Platinum-based Anticancer APIs, Product Type & Application

Table 36. Global Key Manufacturers of Platinum-based Anticancer APIs, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Platinum-based Anticancer APIs Sales by Company (2020-2025) & (MT)

Table 39. North America Platinum-based Anticancer APIs Sales Market Share by Company (2020-2025)

Table 40. North America Platinum-based Anticancer APIs Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Platinum-based Anticancer APIs Revenue Market Share by Company (2020-2025)

Table 42. North America Platinum-based Anticancer APIs Sales by Type (2020-2025) & (MT)

Table 43. North America Platinum-based Anticancer APIs Sales Market Share by Type (2020-2025)

Table 44. North America Platinum-based Anticancer APIs Sales by Application (2020-2025) & (MT)

Table 45. North America Platinum-based Anticancer APIs Sales Market Share by Application (2020-2025)

Table 46. Europe Platinum-based Anticancer APIs Sales by Company (2020-2025) & (MT)

Table 47. Europe Platinum-based Anticancer APIs Sales Market Share by Company (2020-2025)

Table 48. Europe Platinum-based Anticancer APIs Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Platinum-based Anticancer APIs Revenue Market Share by Company (2020-2025)

Table 50. Europe Platinum-based Anticancer APIs Sales by Type (2020-2025) & (MT)

Table 51. Europe Platinum-based Anticancer APIs Sales Market Share by Type (2020-2025)

Table 52. Europe Platinum-based Anticancer APIs Sales by Application (2020-2025) & (MT)

Table 53. Europe Platinum-based Anticancer APIs Sales Market Share by Application (2020-2025)

Table 54. China Platinum-based Anticancer APIs Sales by Company (2020-2025) & (MT)

Table 55. China Platinum-based Anticancer APIs Sales Market Share by Company (2020-2025)

Table 56. China Platinum-based Anticancer APIs Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Platinum-based Anticancer APIs Revenue Market Share by Company (2020-2025)

Table 58. China Platinum-based Anticancer APIs Sales by Type (2020-2025) & (MT)

Table 59. China Platinum-based Anticancer APIs Sales Market Share by Type (2020-2025)

Table 60. China Platinum-based Anticancer APIs Sales by Application (2020-2025) & (MT)

Table 61. China Platinum-based Anticancer APIs Sales Market Share by Application (2020-2025)

Table 62. India Platinum-based Anticancer APIs Sales by Company (2020-2025) & (MT)

Table 63. India Platinum-based Anticancer APIs Sales Market Share by Company (2020-2025)

Table 64. India Platinum-based Anticancer APIs Revenue by Company (2020-2025) & (US$ Million)

Table 65. India Platinum-based Anticancer APIs Revenue Market Share by Company (2020-2025)

Table 66. India Platinum-based Anticancer APIs Sales by Type (2020-2025) & (MT)

Table 67. India Platinum-based Anticancer APIs Sales Market Share by Type (2020-2025)

Table 68. India Platinum-based Anticancer APIs Sales by Application (2020-2025) & (MT)

Table 69. India Platinum-based Anticancer APIs Sales Market Share by Application (2020-2025)

Table 70. Jiangsu Hengrui Medicine Company Information

Table 71. Jiangsu Hengrui Medicine Description and Business Overview

Table 72. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 73. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product

Table 74. Jiangsu Hengrui Medicine Recent Development

Table 75. Nanjing Pharmaceutical Factory Company Information

Table 76. Nanjing Pharmaceutical Factory Description and Business Overview

Table 77. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 78. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product

Table 79. Nanjing Pharmaceutical Factory Recent Development

Table 80. Qilu Pharmaceutical Company Information

Table 81. Qilu Pharmaceutical Description and Business Overview

Table 82. Qilu Pharmaceutical Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 83. Qilu Pharmaceutical Platinum-based Anticancer APIs Product

Table 84. Qilu Pharmaceutical Recent Development

Table 85. Neptunus Company Information

Table 86. Neptunus Description and Business Overview

Table 87. Neptunus Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 88. Neptunus Platinum-based Anticancer APIs Product

Table 89. Neptunus Recent Development

Table 90. Hisun Company Information

Table 91. Hisun Description and Business Overview

Table 92. Hisun Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 93. Hisun Platinum-based Anticancer APIs Product

Table 94. Hisun Recent Development

Table 95. Jiangsu HaiCi biological pharmaceutical Company Information

Table 96. Jiangsu HaiCi biological pharmaceutical Description and Business Overview

Table 97. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 98. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product

Table 99. Jiangsu HaiCi biological pharmaceutical Recent Development

Table 100. Kunming Guiyan Pharmaceutical Company Information

Table 101. Kunming Guiyan Pharmaceutical Description and Business Overview

Table 102. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 103. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product

Table 104. Kunming Guiyan Pharmaceutical Recent Development

Table 105. Lingnan Pharmacy Company Information

Table 106. Lingnan Pharmacy Description and Business Overview

Table 107. Lingnan Pharmacy Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 108. Lingnan Pharmacy Platinum-based Anticancer APIs Product

Table 109. Lingnan Pharmacy Recent Development

Table 110. Jinzhou Jiutai Pharmaceutical Company Information

Table 111. Jinzhou Jiutai Pharmaceutical Description and Business Overview

Table 112. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 113. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product

Table 114. Jinzhou Jiutai Pharmaceutical Recent Development

Table 115. Nanjing Hairun Pharmaceutical Company Information

Table 116. Nanjing Hairun Pharmaceutical Description and Business Overview

Table 117. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 118. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product

Table 119. Nanjing Hairun Pharmaceutical Recent Development

Table 120. Simcere Company Information

Table 121. Simcere Description and Business Overview

Table 122. Simcere Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 123. Simcere Platinum-based Anticancer APIs Product

Table 124. Simcere Recent Development

Table 125. Teva Company Information

Table 126. Teva Description and Business Overview

Table 127. Teva Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 128. Teva Platinum-based Anticancer APIs Product

Table 129. Teva Recent Development

Table 130. Cipla Company Information

Table 131. Cipla Description and Business Overview

Table 132. Cipla Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 133. Cipla Platinum-based Anticancer APIs Product

Table 134. Cipla Recent Development

Table 135. Heraeus Company Information

Table 136. Heraeus Description and Business Overview

Table 137. Heraeus Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 138. Heraeus Platinum-based Anticancer APIs Product

Table 139. Heraeus Recent Development

Table 140. Hospira(Pfizer) Company Information

Table 141. Hospira(Pfizer) Description and Business Overview

Table 142. Hospira(Pfizer) Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 143. Hospira(Pfizer) Platinum-based Anticancer APIs Product

Table 144. Hospira(Pfizer) Recent Development

Table 145. Taj Pharmaceuticals Company Information

Table 146. Taj Pharmaceuticals Description and Business Overview

Table 147. Taj Pharmaceuticals Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 148. Taj Pharmaceuticals Platinum-based Anticancer APIs Product

Table 149. Taj Pharmaceuticals Recent Development

Table 150. Umicore Precious Metals Chemistry Company Information

Table 151. Umicore Precious Metals Chemistry Description and Business Overview

Table 152. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 153. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product

Table 154. Umicore Precious Metals Chemistry Recent Development

Table 155. Production Base and Market Concentration Rate of Raw Material

Table 156. Key Suppliers of Raw Materials

Table 157. Platinum-based Anticancer APIs Distributors List

Table 158. Platinum-based Anticancer APIs Customers List

Table 159. Platinum-based Anticancer APIs Market Trends

Table 160. Platinum-based Anticancer APIs Market Drivers

Table 161. Platinum-based Anticancer APIs Market Challenges

Table 162. Platinum-based Anticancer APIs Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Platinum-based Anticancer APIs Product Picture

Figure 2. Global Platinum-based Anticancer APIs Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Platinum-based Anticancer APIs Sales Market Share by Type in 2024 & 2031

Figure 4. Cisplatin Product Picture

Figure 5. Carboplatin Product Picture

Figure 6. Oxaliplatin Product Picture

Figure 7. Nedaplatin Product Picture

Figure 8. Others Product Picture

Figure 9. Global Platinum-based Anticancer APIs Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 10. Global Platinum-based Anticancer APIs Sales Market Share by Application in 2024 & 2031

Figure 11. Testicular Cancer Examples

Figure 12. Osteosarcoma Examples

Figure 13. Breast Cancer Examples

Figure 14. Esophageal Cancer Examples

Figure 15. NSCLC Examples

Figure 16. Other Examples

Figure 17. Global Platinum-based Anticancer APIs Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Platinum-based Anticancer APIs Sales Growth Rate (2020-2031) & (US$ Million)

Figure 19. Global Platinum-based Anticancer APIs Sales (MT) Growth Rate (2020-2031)

Figure 20. Global Platinum-based Anticancer APIs Price Trends Growth Rate (2020-2031) & (US$/MT)

Figure 21. Platinum-based Anticancer APIs Report Years Considered

Figure 22. Global Market Platinum-based Anticancer APIs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 23. Global Platinum-based Anticancer APIs Revenue Market Share by Region: 2020 VS 2024

Figure 24. North America Platinum-based Anticancer APIs Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. North America Platinum-based Anticancer APIs Sales (MT) Growth Rate (2020-2031)

Figure 26. Europe Platinum-based Anticancer APIs Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. Europe Platinum-based Anticancer APIs Sales (MT) Growth Rate (2020-2031)

Figure 28. China Platinum-based Anticancer APIs Revenue (US$ Million) Growth Rate (2020-2031)

Figure 29. China Platinum-based Anticancer APIs Sales (MT) Growth Rate (2020-2031)

Figure 30. India Platinum-based Anticancer APIs Revenue (US$ Million) Growth Rate (2020-2031)

Figure 31. India Platinum-based Anticancer APIs Sales (MT) Growth Rate (2020-2031)

Figure 32. Global Platinum-based Anticancer APIs Revenue Share by Type (2020-2025)

Figure 33. Global Platinum-based Anticancer APIs Sales Share by Type (2026-2031)

Figure 34. Global Platinum-based Anticancer APIs Revenue Share by Type (2026-2031)

Figure 35. Global Platinum-based Anticancer APIs Revenue Share by Application (2020-2025)

Figure 36. Global Platinum-based Anticancer APIs Revenue Growth Rate by Application in 2020 & 2024

Figure 37. Global Platinum-based Anticancer APIs Sales Share by Application (2026-2031)

Figure 38. Global Platinum-based Anticancer APIs Revenue Share by Application (2026-2031)

Figure 39. Global Platinum-based Anticancer APIs Sales Share by Company (2024)

Figure 40. Global Platinum-based Anticancer APIs Revenue Share by Company (2024)

Figure 41. Global 5 Largest Platinum-based Anticancer APIs Players Market Share by Revenue in Platinum-based Anticancer APIs: 2020 & 2024

Figure 42. Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 43. Manufacturing Cost Structure of Platinum-based Anticancer APIs

Figure 44. Manufacturing Process Analysis of Platinum-based Anticancer APIs

Figure 45. Platinum-based Anticancer APIs Industrial Chain

Figure 46. Channels of Distribution (Direct Vs Distribution)

Figure 47. Distributors Profiles

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Platinum-based Anticancer APIs market? zhanKai

The top companies in the global Platinum-based Anticancer APIs market are Jiangsu Hengrui Medicine、Nanjing Pharmaceutical Factory、Qilu Pharmaceutical.

Related Reports

Platinum-based Anticancer APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Platinum-based Anticancer APIs was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 154
USD 3950.00
(Single User License)
Global Platinum-based Anticancer APIs Market Research Report 2026
The global Platinum-based Anticancer APIs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 152
USD 2900.00
(Single User License)
Global Platinum-based Anticancer APIs Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Platinum-based Anticancer APIs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-24
Pages: 175
USD 4900.00
(Single User License)
Platinum-based Anticancer APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Platinum-based Anticancer APIs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 142
USD 3950.00
(Single User License)
Global Platinum-based Anticancer APIs Market Research Report 2025
The global market for Platinum-based Anticancer APIs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 110
USD 2900.00
(Single User License)
Global Platinum-based Anticancer APIs Market Insights, Forecast to 2030
The global Platinum-based Anticancer APIs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-07
Pages: 115
USD 4900.00
(Single User License)
Platinum-based Anticancer APIs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Platinum-based Anticancer APIs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-19
Pages: 141
USD 3950.00
(Single User License)
Global Platinum-based Anticancer APIs Market Research Report 2024
The global Platinum-based Anticancer APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 112
USD 2900.00
(Single User License)

Platinum-based Anticancer APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Platinum-based Anticancer APIs was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 154
USD 3950.00 (Single User License)
Global Platinum-based Anticancer APIs Market Research Report 2026
The global Platinum-based Anticancer APIs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 152
USD 2900.00 (Single User License)
Global Platinum-based Anticancer APIs Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Platinum-based Anticancer APIs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-24
Pages: 175
USD 4900.00 (Single User License)
Platinum-based Anticancer APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Platinum-based Anticancer APIs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 142
USD 3950.00 (Single User License)
Global Platinum-based Anticancer APIs Market Research Report 2025
The global market for Platinum-based Anticancer APIs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 110
USD 2900.00 (Single User License)
Global Platinum-based Anticancer APIs Market Insights, Forecast to 2030
The global Platinum-based Anticancer APIs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-07
Pages: 115
USD 4900.00 (Single User License)
Platinum-based Anticancer APIs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Platinum-based Anticancer APIs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 141
USD 3950.00 (Single User License)
Global Platinum-based Anticancer APIs Market Research Report 2024
The global Platinum-based Anticancer APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 112
USD 2900.00 (Single User License)